Point72 Europe’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91M | Sell |
134,955
-154,800
| -53% | -$3.34M | 0.11% | 119 |
|
|
2025
Q1 | $4.81M | Buy |
289,755
+116,600
| +67% | +$1.94M | 0.33% | 89 |
|
|
2024
Q4 | $3.18M | Buy |
+173,155
| New | +$3.18M | 0.18% | 96 |
|
|
2024
Q3 | – | Sell |
-50,600
| Closed | -$822K | – | 118 |
|
|
2024
Q2 | $822K | Buy |
+50,600
| New | +$822K | 0.07% | 122 |
|